Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003

ClinicalTrials.gov ID: NCT01856309

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01856309. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (Sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety and efficacy of CNTO 136 (sirukumab) in participants with rheumatoid arthritis (RA) who are unresponsive to treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents.

Study identification

NCT ID: NCT01856309
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Janssen Research & Development, LLC; Industry
Enrollment: 1,820 participants

Conditions and interventions

Conditions

Arthritis, Rheumatoid

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 7, 2013 (Actual)
Primary completion: Apr 30, 2018 (Actual)
Completion: Apr 30, 2018 (Actual)
Last update posted: May 6, 2019

2013 – 2018

United States locations

U.S. sites: 66
U.S. states: 24
U.S. cities: 66

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	—	—
Not listed	Glendale	Arizona	—	—
Not listed	Mesa	Arizona	—	—
Not listed	Peoria	Arizona	—	—
Not listed	Phoenix	Arizona	—	—
Not listed	Covina	California	—	—
Not listed	El Cajon	California	—	—
Not listed	Glendale	California	—	—
Not listed	Hemet	California	—	—
Not listed	Huntington Beach	California	—	—
Not listed	La Jolla	California	—	—
Not listed	La Palma	California	—	—
Not listed	Placentia	California	—	—
Not listed	Upland	California	—	—
Not listed	Victorville	California	—	—
Not listed	Whittier	California	—	—
Not listed	Hamden	Connecticut	—	—
Not listed	Aventura	Florida	—	—
Not listed	Boca Raton	Florida	—	—
Not listed	Brandon	Florida	—	—
Not listed	Daytona Beach	Florida	—	—
Not listed	DeBary	Florida	—	—
Not listed	Miami	Florida	—	—
Not listed	Orlando	Florida	—	—
Not listed	Palm Harbor	Florida	—	—
Not listed	Plantation	Florida	—	—
Not listed	Sarasota	Florida	—	—
Not listed	Tampa	Florida	—	—
Not listed	Zephyrhills	Florida	—	—
Not listed	Cedar Rapids	Iowa	—	—
Not listed	Bowling Green	Kentucky	—	—
Not listed	Monroe	Louisiana	—	—
Not listed	Cumberland	Maryland	—	—
Not listed	Hagerstown	Maryland	—	—
Not listed	Wheaton	Maryland	—	—
Not listed	Rochester	Minnesota	—	—
Not listed	Flowood	Mississippi	—	—
Not listed	Springfield	Missouri	—	—
Not listed	St Louis	Missouri	—	—
Not listed	Omaha	Nebraska	—	—
Not listed	Las Vegas	Nevada	—	—
Not listed	Freehold	New Jersey	—	—
Not listed	Albuquerque	New Mexico	—	—
Not listed	Brooklyn	New York	—	—
Not listed	Charlotte	North Carolina	—	—
Not listed	Cincinnati	Ohio	—	—
Not listed	Columbus	Ohio	—	—
Not listed	Dayton	Ohio	—	—
Not listed	Middleburg Heights	Ohio	—	—
Not listed	Edmond	Oklahoma	—	—
Not listed	Tulsa	Oklahoma	—	—
Not listed	Duncansville	Pennsylvania	—	—
Not listed	Wyomissing	Pennsylvania	—	—
Not listed	Charleston	South Carolina	—	—
Not listed	Austin	Texas	—	—
Not listed	Carrollton	Texas	—	—
Not listed	Corpus Christi	Texas	—	—
Not listed	Cypress	Texas	—	—
Not listed	Dallas	Texas	—	—
Not listed	Houston	Texas	—	—
Not listed	Katy	Texas	—	—
Not listed	Lubbock	Texas	—	—
Not listed	Mesquite	Texas	—	—
Not listed	Victoria	Texas	—	—
Not listed	Beckley	West Virginia	—	—
Not listed	Clarksburg	West Virginia	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 131 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01856309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 6, 2019 · Synced Nov 12, 2026